{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:51:48Z","timestamp":1776091908873,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,21]]},"DOI":"10.7759\/cureus.88465","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:59:42Z","timestamp":1753142382000},"source":"Crossref","is-referenced-by-count":1,"title":["Rituximab-Induced Serum Sickness in a Seven-Year-Old Child With Nephrotic Syndrome"],"prefix":"10.7759","author":[{"given":"Joaquin","family":"Mauvezin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cairus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Inthamoussu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Giachetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpedi.2020.12.010","article-title":"Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: a tertiary hospital [article in Spanish]","author":"Guzm\u00e1n Morais B","year":"2021","unstructured":"Guzm\u00e1n Morais B, Ord\u00f3\u00f1ez \u00c1lvarez F\u00c1, Santos Rodr\u00edguez F, Mart\u00edn Ramos S, Fern\u00e1ndez Novo G. Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: a tertiary hospital [article in Spanish]. An Pediatr (Engl Ed). 2021, 10.1016\/j.anpedi.2020.12.010","journal-title":"An Pediatr (Engl Ed)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc063706","article-title":"Rituximab in patients with the steroid-resistant nephrotic syndrome","volume":"356","author":"Bagga A","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med. 2007, 356:2751-2. 10.1056\/NEJMc063706","journal-title":"N Engl J Med"},{"key":"ref3","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA), Ministry of Health, Labour and Welfare. Report on the deliberation results. Rituxan injection 10 mg\/mL (rituximab). (2014). Accessed: October 16, 2024: https:\/\/www.pmda.go.jp\/files\/000210319.pdf."},{"key":"ref4","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Gu\u00eda para la preparaci\u00f3n de planes de respuesta ante emergencias sanitarias [source in Spanish]. (2020). Accessed. February 26, 2025: https:\/\/iris.paho.org\/handle\/10665.2\/51553."},{"key":"ref5","article-title":"Ficha t\u00e9cnica de MabThera 100 y 500 mg, soluci\u00f3n para perfusi\u00f3n [Internet]. Madrid: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Accessed: February 26, 2025","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Ficha t\u00e9cnica de MabThera 100 y 500 mg, soluci\u00f3n para perfusi\u00f3n. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios, Madrid; https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/98067002\/FT_98067002.htm."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.06.009","article-title":"Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study","volume":"67","author":"Bayer G","year":"2019","unstructured":"Bayer G, Agier MS, Lioger B, et al.. Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study. Eur J Intern Med. 2019, 67:59-64. 10.1016\/j.ejim.2019.06.009","journal-title":"Eur J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.014","article-title":"Rituximab-induced serum sickness: A systematic review","volume":"45","author":"Karmacharya P","year":"2015","unstructured":"Karmacharya P, Poudel DR, Pathak R, et al.. Rituximab-induced serum sickness: A systematic review. Semin Arthritis Rheum. 2015, 45:334-40. 10.1016\/j.semarthrit.2015.06.014","journal-title":"Semin Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-017-0297-7","article-title":"Serum sickness with refractory nephrotic syndrome following treatment with rituximab","volume":"7","author":"Maeda R","year":"2018","unstructured":"Maeda R, Kawasaki Y, Ohara S, Suyama K, Hosoya M. Serum sickness with refractory nephrotic syndrome following treatment with rituximab. CEN Case Rep. 2018, 7:69-72. 10.1007\/s13730-017-0297-7","journal-title":"CEN Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300462","article-title":"Management of a child with suspected acute septic arthritis","volume":"97","author":"P\u00e4\u00e4kk\u00f6nen M","year":"2012","unstructured":"P\u00e4\u00e4kk\u00f6nen M, Peltola H. Management of a child with suspected acute septic arthritis. Arch Dis Child. 2012, 97:287-92. 10.1136\/archdischild-2011-300462","journal-title":"Arch Dis Child"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-022-00709-y","article-title":"Rituximab-induced serum sickness in a girl with nephrotic syndrome","volume":"11","author":"Kimura Y","year":"2022","unstructured":"Kimura Y, Kiyota K, Ikeuchi M, Sekiguchi K, Ihara K. Rituximab-induced serum sickness in a girl with nephrotic syndrome. CEN Case Rep. 2022, 11:506-10. 10.1007\/s13730-022-00709-y","journal-title":"CEN Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ped.14738","article-title":"Rituximab-induced serum sickness with idiopathic nephrotic syndrome in a child","volume":"64","author":"Majima H","year":"2022","unstructured":"Majima H, Kasahara K, Gotoh Y. Rituximab-induced serum sickness with idiopathic nephrotic syndrome in a child. Pediatr Int. 2022, 64:e14738. 10.1111\/ped.14738","journal-title":"Pediatr Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-020-00449-x","article-title":"Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome","volume":"9","author":"Nakamura M","year":"2020","unstructured":"Nakamura M, Kanda S, Yoshioka Y, et al.. Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome. CEN Case Rep. 2020, 9:173-6. 10.1007\/s13730-020-00449-x","journal-title":"CEN Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2020.05.025","article-title":"Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome","volume":"62","author":"Bayram MT","year":"2020","unstructured":"Bayram MT, Soylu A, Kavuk\u00e7u S. Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome. Turk J Pediatr. 2020, 62:884-8. 10.24953\/turkjped.2020.05.025","journal-title":"Turk J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05175-9","article-title":"Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study","volume":"37","author":"Vivarelli M","year":"2022","unstructured":"Vivarelli M, Colucci M, Gargiulo A, Bettini C, Lo Russo A, Emma F. Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study. Pediatr Nephrol. 2022, 37:377-83. 10.1007\/s00467-021-05175-9","journal-title":"Pediatr Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359416-rituximab-induced-serum-sickness-in-a-seven-year-old-child-with-nephrotic-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:59:46Z","timestamp":1753142386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359416-rituximab-induced-serum-sickness-in-a-seven-year-old-child-with-nephrotic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.88465","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}